Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.38 USD | -1.90% | -3.74% | -4.16% |
May. 10 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
Mar. 05 | Top Premarket Gainers | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.09M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -10M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.56
x | P/E ratio 2025 * |
-2.63
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.55% |
1 day | -1.90% | ||
1 week | -3.74% | ||
Current month | -1.42% | ||
1 month | -0.90% | ||
3 months | -12.60% | ||
6 months | +34.77% | ||
Current year | -4.16% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Michael Brooks
PSD | President | 46 | 15-08-31 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 23-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 19-06-06 |
Frank Oakes
BRD | Director/Board Member | 73 | 10-04-08 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 4.38 | -1.90% | 14,283 |
24-05-23 | 4.465 | -2.33% | 18,393 |
24-05-22 | 4.571 | +0.47% | 7,990 |
24-05-21 | 4.55 | -4.01% | 9,238 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.16% | 14.09M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- EDSA Stock